OPZELURA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50881-007
  • Package NDC 50881-007-04
  • Package NDC 50881-007-05
  • Package NDC 50881-007-07
  • Package NDC 50881-007-14
  • Application number NDA215309
  • SPL ID af30042b-ecb2-4e8b-82be-117685dff4ed
  • SPL set ID 24da5509-6631-4795-9d42-273faecd08e7
  • UNII 436LRU32H5
  • RxCUI 2570752
  • RxCUI 2570757

What the source publishes

Labeler
Incyte Corporation
Active ingredients
ruxolitinib
Form
CREAM
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50881-007_af30042b-ecb2-4e8b-82be-117685dff4ed
{
  "name": "OPZELURA",
  "splId": "af30042b-ecb2-4e8b-82be-117685dff4ed",
  "labels": [
    {
      "setId": "24da5509-6631-4795-9d42-273faecd08e7",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24da5509-6631-4795-9d42-273faecd08e7",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24da5509-6631-4795-9d42-273faecd08e7"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "Incyte Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": true,
      "description": "1 TUBE in 1 CARTON (50881-007-04)  / 5 g in 1 TUBE",
      "package_ndc": "50881-007-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210921"
    },
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (50881-007-05)  / 60 g in 1 TUBE",
      "package_ndc": "50881-007-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210921"
    },
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (50881-007-07)  / 100 g in 1 TUBE",
      "package_ndc": "50881-007-07",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220415"
    },
    {
      "sample": true,
      "description": "1 TUBE in 1 CARTON (50881-007-14)  / 3 g in 1 TUBE",
      "package_ndc": "50881-007-14",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251110"
    }
  ],
  "productId": "50881-007_af30042b-ecb2-4e8b-82be-117685dff4ed",
  "useDomain": "unknown",
  "dosageForm": "CREAM",
  "productNdc": "50881-007",
  "deaSchedule": null,
  "genericName": "ruxolitinib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RUXOLITINIB PHOSPHATE",
      "strength": "15 mg/g"
    }
  ],
  "applicationNumber": "NDA215309",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210921",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "436LRU32H5"
    ],
    "rxcui": [
      "2570752",
      "2570757"
    ],
    "spl_set_id": [
      "24da5509-6631-4795-9d42-273faecd08e7"
    ],
    "manufacturer_name": [
      "Incyte Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50881-007_af30042b-ecb2-4e8b-82be-117685dff4ed"